Steven Woloshin, MD, MS, a professor of medicine and community and family medicine at Dartmouth’s Geisel School of Medicine, and Lisa Schwartz, MD, MS, his wife and research partner who died in 2018, have received the John E. Eisenberg Award for Practical Application of Medical Decision Making Research from the Society for Medical Decision Making.
Post Tagged with: "Lisa Schwartz"
Giving Context to Cancer Risk
In an effort to give the public a more broad-based view of cancer risk, the National Cancer Institute (NCI) collaborated with Dartmouth Institute researchers and physicians Lisa Schwartz and Steven Woloshin to create the “Know Your Chances” website.
No Matter the Language, Disease Risk Is Hard to Communicate
Science News – This article quotes Lisa Schwartz and Steve Woloshin, both professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on effective disease risk communication and how it’s not just about communicating the numbers of infected and quarantined, but how it’s also about admitting when you don’t have all the answers.
Is It Low-T? No It’s Big Pharma Peddling a Nonexistent Disease
Valley News via Washington Post – Continued coverage of an opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.
Sell a disease to sell a drug
Washington Post – An opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.
Dartmouth Faculty Form New Venture to Help Consumers Get the Facts on Prescription Drugs
Professors Lisa Schwartz and Steve Woloshin aim to provide people with information about the benefits and harms of prescription drugs through use of a formulary, or drug database.